Scientist and Partners
Expert behind our Research and Development
Dr. Priti Vaidyanathan
Board Advisor
Dr. Richa Srivastava
Innovation Scientist
NBI Biosciences
Dr. Madhukar Saxena
Head R&D / Chemzin Biotox Research
Dr. Sandeep Jain
Principal Architect
Oniosome
Dr. Parthasarathi Ramakrishnan
Principal Scientist, CSIR
Dr. P. Giridhar
Principal Scientist
CFTRI
Dr. P. Giridhar
Over the last 25-years his research focuses on the themes of food biotechnology specifically in the interface of plants and nutraceuticals including Plant Tissue Culture, Molecular biology, Metabolic engineering, Plant Secondary metabolites, Phytonutrients and nutraceuticals, Functional food formulations. So far, he has successfully developed two processes, 09 patents and authored more than 200 publications.
Dr. Saurabh Srivastava
He carries more than 17-years of profound industrial and research experience working with several Pharmaceutical R&Ds, including IPCA labs, Wockhardt research center, and Dr. Reddy’s Laboratories, as Tech Lead for development and commercialization of various formulation for different regulated markets around Neurodegenerative disorders, Psoriasis, targeted drug delivery and cancers.
Mr. Sandeep Jain
He is an M. Pharm (Pharmaceuticals) graduate for about one decades of experience across Research & Development. He is well versed with the overall management of the company and possesses vast amount of hands-on experience in research and formulation development.
Dr. Madhukar Saxena
Dr. Saxena has established himself as a prolific author, publishing numerous articles and reviews in prestigious, peer-reviewed journals. His scholarly contributions also include books that have gained international acclaim, solidifying his reputation as a thought leader in his field. A central theme of his research is the exploration and elucidation of the intricate inflammatory networks that are key drivers of metabolic disorders, particularly Type 2 Diabetes Mellitus (T2DM). His work has been instrumental in explaining how chronic, low-grade inflammation can contribute to insulin resistance and other disease pathologies. His core expertise is built on a foundation of several key disciplines including Molecular Genetics, Biochemistry, Preclinical Toxicology and Bioinformatics.
A hallmark of Dr. Saxena’s scientific approach is his deep commitment to understanding the fundamental mechanisms of disease. His findings help pinpoint potential therapeutic targets and predict how new drugs might interact with the body.
Dr. Saxena’s professional journey reflects a steady ascent into scientific leadership. He eventually rose to the position of Vice President at Chemzin Biotox Research Institute. In this leadership role, he has worked closely with a wide range of organizations, including government bodies, academic institutions, and Contract Research Organizations (CROs). These partnerships have been vital for translating his scientific discoveries into practical applications.
Notably, Dr. Saxena has played a pivotal role in shaping the strategic direction for NBI formulations. His expertise has been critical in developing detailed roadmaps for the essential preclinical animal studies required for regulatory approval. This work highlights his comprehensive knowledge, not just in basic research, but also in the crucial steps of drug development and regulatory science.
Dr. Richa Srivastava
She has over 20-years of post-doctoral experience in the field of Drug discovery, Virology, Toxicology, Immunology and Molecular Oncology from organizations such as IITR-CSIR, CFTRI-CSIR and NICPR-ICMR and published 30 Research publication in highly reputed International Journals, book chapters and books as well.
Dr. Parthasarathi Ramakrishnan
Dr. Partha earned his PhD from CLRI, University of Madras and he served as a scientist with highly reputed institutions like the Lawrence Berkeley National Labs, Los Alamos National Laboratory, and Sandia National Laboratories, USA. He has more than 20 years of research experience in applied biochemistry to unravel important issues in human health and the environment. His lab is currently involved in the development of AI & Machine Learning based computational toxicity models, biomolecular simulations, databases, and developing innovative predictive approaches relevant to translational research.
Dr. Priti Vaidyanathan
She has undergone special training on Metabolomics from Leiden University, Netherlands. Her rich experience in natural product chemistry comes from post-doctoral positions at Agricultural University and Indian Institute of Science, Bangalore. She has over 20 publications in peer reviewed journals and 4 patents in her name. Through her career, she has worked with multiple functions such as raw material procurement, extraction & isolation, formulation development and clinical research teams, thus having a 360o understanding of natural product development. A University Gold Medalist, she has also won the DST award and participated in several national and international conferences / workshops.